Merck raised its 2026 revenue forecast after reporting stronger second-quarter sales on August 4 at its headquarters in Rahway, New Jersey. However, the company sharply reduced its adjusted earnings guidance because of charges linked to its acquisitions of Terns Pharmaceuticals
